Syncona
+9

Oct 2, 2026
•
7 min read
Biogen and Johnson and Johnson both tried to treat an inherited form of blindness by delivering a working copy of the same faulty gene, and both trials missed. Beacon Therapeutics just hit its primary endpoint in an 85-patient trial. The honest question is whether its therapy is actually better, or whether it picked the finish line the first two had already found easier.
Space
+10

Sep 25, 2026
•
7 min read
Icarus Robotics took JOY into repeated weightlessness to test the part simulators struggle with: when a robot reaches for an object in microgravity, the robot itself moves. The next stop is meant to be the International Space Station in 2027.
Quobly
+8

Sep 23, 2026
•
6 min read
Quobly says a single chip made on STMicroelectronics' standard 300 mm production line performed qubit readout plus single- and two-qubit gates. The milestone is not the qubit count. It is the attempt to turn quantum hardware from craft production into semiconductor manufacturing.
QLDPC
+5

Sep 4, 2026
•
6 min read
Error correction works. That was settled this year. What nobody puts on a slide is the exchange rate: roughly a thousand fragile physical qubits to buy one reliable logical one, which lands a useful machine at millions of qubits against the few thousand that exist. A new family of codes published in Nature Communications claims to cut that ratio twenty-fold. Here is how, and the condition attached to it.